Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Francini G

Collect these papers and discover other ones on Labmeeting. Learn more.

Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.

+ cite this

+ View Abstract

Petrioli R, Bargagli G, Lazzi S, Pascucci A, Francini E, Bellan C, Conca R, Martellucci I, Fiaschi AI, Lorenzi B, Francini G, and Multidisciplinary Oncology Group in Gastrointestinal Tumors

Anti-cancer drugs 21(3):313-9, 2010 Mar - Who cited this? | PubMed ID: 20016369 | Fulltext

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

+ cite this

+ View Abstract

Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, and de Gramont A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(6):872-7, 2009 Feb 20 - Who cited this? | PubMed ID: 19124803 | Fulltext

The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.

+ cite this

+ View Abstract

Petrioli R, Fiaschi AI, Francini E, Pascucci A, and Francini G

Cancer treatment reviews 34(8):710-8, 2008 Dec - Who cited this? | PubMed ID: 18620815 | Fulltext

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial).

+ cite this

+ View Abstract

Correale P, Tagliaferri P, Fioravanti A, del Vecchio MT, Remondo C, Montagnani F, Rotundo MS, Ginanneschi C, Martellucci I, Francini E, Cusi MG, Tassone P, and Francini G

Clinical cancer research : an official journal of the American Association for Cancer Research 14(13):4192, 2008 Jul 1 - Who cited this? | PubMed ID: 18593999 | Fulltext

Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine.

+ cite this

+ View Abstract

Correale P, Vecchio MT, Renieri T, Genova GD, Placa ML, Remondo C, Savellini GG, Terrosi C, Zurbriggen R, Amacker M, Francini G, and Cusi MG

Cancer letters 263(2):291-301, 2008 May 18 - Who cited this? | PubMed ID: 18291576 | Fulltext

Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen.

+ cite this

+ View Abstract

Correale P, Fioravanti A, Bertoldi I, Montagnani F, Miracco C, and Francini G

Journal of chemotherapy (Florence, Italy) 20(2):278-81, 2008 Apr - Who cited this? | PubMed ID: 18467257 | Fulltext

Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer.

+ cite this

+ View Abstract

Francini G, Paolelli L, Francini E, Pascucci A, Manganelli A, Salvestrini F, and Petrioli R

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 34(2):216-21, 2008 Feb - Who cited this? | PubMed ID: 17502132 | Fulltext

Biweekly Triple Combination Chemotherapy with Gemcitabine, Oxaliplatin, Levofolinic Acid and 5-Fluorouracil (GOLF) Is a Safe and Active Treatment 5-Fluorouracil (GOLF) Is a Safe and Active Treatment.

+ cite this

+ View Abstract

Correale P, Montagnani F, Miano S, Sciandivasci A, Pascucci A, Petrioli R, Testi W, Tanzini G, and Francini G

Journal of chemotherapy (Florence, Italy) 20(1):119-25, 2008 Feb - Who cited this? | PubMed ID: 18343754 | Fulltext

Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.

+ cite this

+ View Abstract

Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, Tassi R, Civitelli S, Tanzini G, Lorenzi M, and Francini G

Cancer chemotherapy and pharmacology 61(1):105-11, 2008 Jan - Who cited this? | PubMed ID: 17429632 | Fulltext

Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.

+ cite this

+ View Abstract

Petrioli R, Pascucci A, Francini E, Marsili S, Fiaschi AI, Civitelli S, Tanzini G, Battistelli S, Lorenzi M, Roviello F, and Francini G

Anti-cancer drugs 19(1):91-6, 2008 Jan - Who cited this? | PubMed ID: 18043134 | Fulltext

Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.

+ cite this

+ View Abstract

Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova G, Savellini GG, Terrosi C, Mannucci S, Giorgi G, Francini G, and Cusi MG

Journal of immunotherapy (Hagerstown, Md. : 1997) 31(2):132-47, 2008 - Who cited this? | PubMed ID: 18481383 | Fulltext

Method of animating a synthesized model of a human face driven by an acoustic signal.

+ cite this

Francini G

The Journal of the Acoustical Society of America 122(6):3154, 2007 Dec - Who cited this? | PubMed ID: 18247714 | Fulltext

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

+ cite this

+ View Abstract

Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Kerr D, Green E,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(29):4569-74, 2007 Oct 10 - Who cited this? | PubMed ID: 17876008 | Fulltext

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel.

+ cite this

+ View Abstract

Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, De Rubertis G, Barbanti G, Manganelli A, Salvestrini F, and Francini G

BJU international 100(4):775-9, 2007 Oct - Who cited this? | PubMed ID: 17535276 | Fulltext

Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy.

+ cite this

+ View Abstract

Petrioli R, Paolelli L, Francini E, Marsili S, Pascucci A, Sciandivasci A, de Rubertis G, Barbanti G, Manganelli A, Salvestrini F, and Francini G

Anti-cancer drugs 18(7):817-20, 2007 Aug - Who cited this? | PubMed ID: 17581304 | Fulltext

Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.

+ cite this

+ View Abstract

Correale P, Sciandivasci A, Intrivici C, Pascucci A, Del Vecchio MT, Marsili S, Savelli V, Voltolini L, Di Bisceglie M, Guarnieri A, Gotti G, and Francini G

British journal of cancer 96(9):1343-7, 2007 May 7 - Who cited this? | PubMed ID: 17437022 | Fulltext

Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.

+ cite this

+ View Abstract

Gonnelli S, Cadirni A, Caffarelli C, Petrioli R, Montagnani A, Franci MB, Lucani B, Francini G, and Nuti R

Bone 40(1):205-10, 2007 Jan - Who cited this? | PubMed ID: 16904960 | Fulltext

Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer.

+ cite this

+ View Abstract

Petrioli R, Paolelli L, Francini E, Manganelli A, Salvestrini F, and Francini G

Urology 69(1):142-6, 2007 Jan - Who cited this? | PubMed ID: 17270637 | Fulltext

Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids.

+ cite this

+ View Abstract

Francini G, Petrioli R, Montagnani A, Cadirni A, Campagna S, Francini E, and Gonnelli S

British journal of cancer 95(2):153-8, 2006 Jul 17 - Who cited this? | PubMed ID: 16835585 | Fulltext

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients.

+ cite this

+ View Abstract

Correale P, Cerretani D, Remondo C, Martellucci I, Marsili S, La Placa M, Sciandivasci A, Paolelli L, Pascucci A, Rossi M, Di Bisceglie M, Giorgi G, Gotti G, and Francini G

Oncology reports 16(1):133-40, 2006 Jul - Who cited this? | PubMed ID: 16786136 | Fulltext

Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.

+ cite this

+ View Abstract

Correale P, Cusi MG, Micheli L, Nencini C, Del Vecchio MT, Torino F, Aquino A, Bonmassar E, Francini G, and Giorgi G

Investigational new drugs 24(2):99-110, 2006 Mar - Who cited this? | PubMed ID: 16502353 | Fulltext

FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer.

+ cite this

+ View Abstract

Petrioli R, Paolelli L, Marsili S, Civitelli S, Francini E, Cioppa T, Roviello F, Nettuno R, Intrivici C, Tanzini G, Lorenzi M, and Francini G

Oncology 70(5):345-50, 2006 - Who cited this? | PubMed ID: 17179728 | Fulltext

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.

+ cite this

+ View Abstract

Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, and Francini G

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23(35):8950-8, 2005 Dec 10 - Who cited this? | PubMed ID: 16061910 | Fulltext

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

+ cite this

+ View Abstract

Correale P, Fulfaro F, Marsili S, Cicero G, Bajardi E, Intrivici C, Vuolo G, Carli AF, Caraglia M, Del Prete S, Greco E, Gebbia N, and Francini G

Cancer chemotherapy and pharmacology 56(6):563-8, 2005 Dec - Who cited this? | PubMed ID: 16041610 | Fulltext

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

+ cite this

+ View Abstract

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23(34):8664-70, 2005 Dec 1 - Who cited this? | PubMed ID: 16260700 | Fulltext

5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.

+ cite this

+ View Abstract

Correale P, Del Vecchio MT, Di Genova G, Savellini GG, La Placa M, Terrosi C, Vestri M, Urso R, Lemonnier F, Aquino A, Bonmassar E, Giorgi G, Francini G, and Cusi MG

Journal of the National Cancer Institute 97(19):1437-45, 2005 Oct 5 - Who cited this? | PubMed ID: 16204693 | Fulltext

Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.

+ cite this

+ View Abstract

Caraglia M, Marra M, Budillon A, Meo G, Ricciardiello F, Bismuto E, Brachelente G, Francini G, Giordano A, Correale P, and Abbruzzese A

Cancer biology & therapy 4(10):1159-67, 2005 Oct - Who cited this? | PubMed ID: 16294035 | Fulltext

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

+ cite this

+ View Abstract

Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, and Francini G

Journal of immunology (Baltimore, Md. : 1950) 175(2):820-8, 2005 Jul 15 - Who cited this? | PubMed ID: 16002679 | Fulltext

Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.

+ cite this

+ View Abstract

Cusi MG, Del Vecchio MT, Terrosi C, Savellini GG, Di Genova G, La Placa M, Fallarino F, Moser C, Cardone C, Giorgi G, Francini G, and Correale P

Journal of immunology (Baltimore, Md. : 1950) 174(11):7210-6, 2005 Jun 1 - Who cited this? | PubMed ID: 15905566 | Fulltext

Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2.

+ cite this

+ View Abstract

Correale P, Marsili S, Sabatino M, Montagnani F, Giorgi G, and Francini G

Oncology reports 13(4):751-6, 2005 Apr - Who cited this? | PubMed ID: 15756453 | Fulltext

Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.

+ cite this

+ View Abstract

Petrioli R, Sabatino M, Roviello F, Marrelli D, Nastri G, Marsili S, Correale P, Pozzessere D, Messinese S, De Martino A, Tani F, Marzocca G, Lorenzi M, Civitelli S, Tanzini G, Pinto E,

(show remaining authors)

Hepato-gastroenterology 52(65):1626-30, 2005 - Who cited this? | PubMed ID: 16201130 | Fulltext

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?.

+ cite this

+ View Abstract

Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, and Goldberg RM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(10):1797-806, 2004 May 15 - Who cited this? | PubMed ID: 15067028 | Fulltext

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

+ cite this

+ View Abstract

Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, and Francini G

British journal of cancer 90(9):1710-4, 2004 May 4 - Who cited this? | PubMed ID: 15150625 | Fulltext

Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies.

+ cite this

+ View Abstract

Correale P, Cerretani D, Clerici M, Messinese S, Marsili S, Petrioli R, Cetta F, Savelli V, Guarnieri A, Pinto E, Giorgi G, and Francini G

Journal of chemotherapy (Florence, Italy) 16(2):206-10, 2004 Apr - Who cited this? | PubMed ID: 15216958 | Fulltext

Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases.

+ cite this

+ View Abstract

Petrioli R, Rossi S, Caniggia M, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Salvestrini F, Manganelli A, and Francini G

Urology 63(2):321-6, 2004 Feb - Who cited this? | PubMed ID: 14972482 | Fulltext

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.

+ cite this

+ View Abstract

Petrioli R, Sabatino M, Fiaschi AI, Marsili S, Pozzessere D, Messinese S, Correale P, Civitelli S, Tanzini G, Tani F, De Martino A, Marzocca G, Lorenzi M, Giorgi G, and Francini G

British journal of cancer 90(2):306-9, 2004 Jan 26 - Who cited this? | PubMed ID: 14735168 | Fulltext

A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.

+ cite this

+ View Abstract

Correale P, Messinese S, Marsili S, Ceciarini F, Pozzessere D, Petrioli R, Sabatino M, Cerretani D, Pellegrini M, Di Palma T, Neri A, Calvanese A, Pinto E, Giorgi G, and Francini G

British journal of cancer 89(2):239-42, 2003 Jul 21 - Who cited this? | PubMed ID: 12865908 | Fulltext

In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse.

+ cite this

+ View Abstract

Scardino A, Correale P, Firat H, Pellegrini M, Kosmatopoulos K, Opolon P, Alves P, Zurbriggen R, Glück R, Lemonnier FA, Francini G, and Cusi MG

British journal of cancer 89(1):199-205, 2003 Jul 7 - Who cited this? | PubMed ID: 12838324 | Fulltext

Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients.

+ cite this

+ View Abstract

Correale P, Cerretani D, Marsili S, Pozzessere D, Petrioli R, Messinese S, Sabatino M, Roviello F, Pinto E, Francini G, and Giorgi G

European journal of cancer (Oxford, England : 1990) 39(11):1547-51, 2003 Jul - Who cited this? | PubMed ID: 12855261 | Fulltext

Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.

+ cite this

+ View Abstract

Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E, and Francini G

International journal of cancer. Journal international du cancer 104(4):437-45, 2003 Apr 20 - Who cited this? | PubMed ID: 12584740 | Fulltext

Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens.

+ cite this

+ View Abstract

Petrioli R, Pozzessere D, Messinese S, Sabatino M, Ceciarini F, Marsili S, Correale P, Fiaschi AI, Voltolini L, Gotti G, and Francini G

Lung cancer (Amsterdam, Netherlands) 39(1):85-9, 2003 Jan - Who cited this? | PubMed ID: 12499099 | Fulltext

Weekly low-dose docetaxel in advanced hormone-resistant prostate cancer patients previously exposed to chemotherapy.

+ cite this

+ View Abstract

Petrioli R, Pozzessere D, Messinese S, Sabatino M, Di Palma T, Marsili S, Correale P, Manganelli A, Salvestrini F, and Francini G

Oncology 64(4):300-5, 2003 - Who cited this? | PubMed ID: 12759524 | Fulltext

High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects.

+ cite this

+ View Abstract

Francini G, Scardino A, Kosmatopoulos K, Lemonnier FA, Campoccia G, Sabatino M, Pozzessere D, Petrioli R, Lozzi L, Neri P, Fanetti G, Cusi MG, and Correale P

Journal of immunology (Baltimore, Md. : 1950) 169(9):4840-9, 2002 Nov 1 - Who cited this? | PubMed ID: 12391194 | Fulltext

Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.

+ cite this

+ View Abstract

Francini G, Petrioli R, Messinese S, Pozzessere D, Marsili S, Correale P, Sabatino M, and Fiaschi AI

Cancer chemotherapy and pharmacology 50(4):271-6, 2002 Oct - Who cited this? | PubMed ID: 12357300 | Fulltext

Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma.

+ cite this

+ View Abstract

Petrioli R, Coratti A, Correale P, D'Aniello C, Grimaldi L, Tanzini G, Civitelli S, Marsili S, Messinese S, Marzocca G, Pirtoli L, and Francini G

American journal of clinical oncology 25(5):468-73, 2002 Oct - Who cited this? | PubMed ID: 12393986 | Fulltext

Weekly epirubicin in patients with hormone-resistant prostate cancer.

+ cite this

+ View Abstract

Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, and Francini G

British journal of cancer 87(7):720-5, 2002 Sep 23 - Who cited this? | PubMed ID: 12232753 | Fulltext

Pharmacokinetics of intraarterial mitomycin C in hypoxic hepatic infusion with embolization in the treatment of liver metastases.

+ cite this

+ View Abstract

Cerretani D, Roviello F, Pieraccini M, Civeli L, Correale P, Francini G, Marrelli D, De Manzoni G, Pinto E, and Giorgi G

Vascular pharmacology 39(1-2):1-6, 2002 Jul - Who cited this? | PubMed ID: 12616984 | Fulltext

A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.

+ cite this

+ View Abstract

Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, and Francini G

British journal of cancer 85(11):1722-30, 2001 Nov 30 - Who cited this? | PubMed ID: 11742494 | Fulltext

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes.

+ cite this

+ View Abstract

Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D, Nencini C, Valensin PE, Petrioli R, Giorgi G, Zurbriggen R, Gluck R, and Francini G

European journal of cancer (Oxford, England : 1990) 37(16):2097-103, 2001 Nov - Who cited this? | PubMed ID: 11597390 | Fulltext

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

+ cite this

+ View Abstract

Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, and Francini G

The New England journal of medicine 345(15):1091-7, 2001 Oct 11 - Who cited this? | PubMed ID: 11596588 | Fulltext

Search Google Scholar for Francini G

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.